Skip to main content
Evidence Snapshot

Sigma non-opioid intracellular receptor 1

CHEMBL4153 SINGLE PROTEIN Cavia porcellus
Source Header

ChEMBL 36 via Core Engine

Target Snapshot 2026-09-13T22:20:29Z
Source · ChEMBL 36 via Core Engine
ChEMBL ChEMBL 36 CHEMBL4153
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sigma non-opioid intracellular receptor 1 as ChEMBL target CHEMBL4153, mapped to UniProt Q60492. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sigma non-opioid intracellular receptor 1
SINGLE PROTEIN · Cavia porcellus
As of 2026-09-13
ChEMBL target ID
CHEMBL4153
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q60492
Sigma non-opioid intracellular receptor 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Review-ready Target Rationale

Why Sigma non-opioid intracellular receptor 1 matters

As of 2026-09-13

Sigma non-opioid intracellular receptor 1 is reviewed as Sigma non-opioid intracellular receptor 1 (UniProt Q60492); the current evidence base includes 13 approved drugs, 3019 compounds, and 308 assays, with lead potency reaching pChEMBL 11.0.

Protein context
Sigma non-opioid intracellular receptor 1

Sigma non-opioid intracellular receptor 1 Sequence length is 223 aa.

Review this target as Sigma non-opioid intracellular receptor 1, mapped to UniProt Q60492. Sequence length is 223 aa.

Protein source · UniProt accession via ChEMBL component mapping
UniProt Q60492 Protein
Disease context
Disease signal

Disease relevance is not yet populated for this evidence card.

This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

ChEMBL target record
Activity base
Portfolio and assay base

ChEMBL currently tracks 13 approved drugs, 3019 compounds, and 308 assays for this target. The dominant activity type is KI. CHEMBL372700 is the current potency anchor at pChEMBL 11.0.

Use CHEMBL372700 as the tractability anchor when discussing potency (pChEMBL 11.0).

Activity source · ChEMBL 36 via Core Engine
13 approved pChEMBL 11.0
Source Guidance

Start with the right source

Pick the first block or linked source that matches the review question in front of you.

Need the shortest review narrative first?
Review-ready Target Rationale
One-page rationale with as-of-date and attribution

Start with the review rationale when you need to explain why Sigma non-opioid intracellular receptor 1 matters before drilling into raw source blocks.

Jump to Review Rationale
Need stable protein naming or accession mapping?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Go back to the target snapshot when you need the naming and mapping contract behind UniProt Q60492, not just the summarized rationale.

Open Protein Context
Need disease fit or evidence level for program framing?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use the target snapshot disease block when you need the disease program and supporting signals, not only the card summary.

Open Disease Context

Snapshot State

No project snapshot selected. Export uses the live evidence card state.

3019
Total Compounds
308
Total Assays
13
Approved Drugs
IC50: 22.0, KI: 3382.0, KD: 2.0
Activity Types

pChEMBL Activity Distribution

Top 5 Inhibitors (by pChEMBL)

Structure Compound pChEMBL Type Phase
No preferred name
CHEMBL372700
11.0 Ki
No preferred name
CHEMBL545278
10.5 Ki
No preferred name
CHEMBL176941
10.5 Ki
10.4 Ki
No preferred name
CHEMBL1917286
10.3 Ki

Approved Drugs

Structure Compound First Approval
PITOLISANT
CHEMBL462605
2016
DOLUTEGRAVIR
CHEMBL1229211
2013
DONEPEZIL
CHEMBL502
1996
DEXTROMETHORPHAN
CHEMBL52440
1982
PROGESTERONE
CHEMBL103
1976
HALOPERIDOL
CHEMBL54
1967
PENTAZOCINE
CHEMBL100116
1967
← Target Page
Source Header

ChEMBL 36 via Core Engine

Target Snapshot 2026-09-13T22:20:29Z
Source · ChEMBL 36 via Core Engine
ChEMBL ChEMBL 36 CHEMBL4153